1Hening W,Earley C,Silber M. The treatment of restless legs syndrome and periodic Cimb movement disorder[J]. An American Acade of Sleep Medicine Review Sleep, 1999,22 (7) : 970-999.
3Allen RP. Restless legs syndrome prevalence and impact:REST general population study [J].Arch Intern Med,2005,165(11) :1286 -1292.
4Chokroverty S, Jankovic J. Restless legs syndrome:a disease in search of identity[J]. Neurology, 1999,52 (5) : 907.
5Collado-Seidel V, Samtleben W, Trenkwalder C. Clinical and bio chemical findings in uremic patients Without restless legs syndrome [J]. Am J Kidney Dis,1998,31(2):324-328.
6Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS)[J]. Sleep Med,2004, 5(4) :385-391.
同被引文献5
1Waiters AS, Le Brocq C, Dhar A, et al. Validation of theinterna- tional restless legs syndrome study group ratingscale for restless legs syndrome[J]. Sleep Med, 2003,4 : 121.
2Thorpy MJ. New paradigms in the treatment of restless legs syn- drom C[J]. Neurology,2005, 64 (12 Suppl 3):S28-S33.
3Grandjean E. Restless legs syndrome. Report of esperience[J]. Schweiz Rundsch Med Prax, 1993,82(43): 1195-1197.
4Stiasny K,Wetter TC,Winkelmann J,et al. Long-term effects of pergolide in the treatment of restless legs syndrome[J]. Neurolo- gy, 2001,56: 1399-1402.
5Davis BJ, Rajput A, Rajput ML. A randomized, double-blind plaee- bo controlled trial of iron in restless legs syndrome[J]. Eur Neu rol, 2000,43 : 70-75.
